COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 818

Article download: 217

IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain


Role of aprepitant in chemotherapy induced nausea and vomiting


Full Text PDF Share on Facebook Share on Twitter


Author Details : Seema Devi, Meka Geeta

Volume : 2, Issue : 2, Year : 2016

Article Page : 35-39


Suggest article by email

Abstract

Background: Nausea and vomiting is the most common adverse effect of most of the chemotherapeutic agents. Large range of antiemetics has been used since ages. Aprepitant is an NK-1 receptor antagonist which blocks the emetic effects of substance P. The present study is to determine the effectiveness of aprepitant in preventing nausea and vomiting in patients receiving chemotherapy when combined with standard regimen.
Methods: In this is an institutional based single arm randomized study patients received aprepitant 125 mg per oral, dexamethasone 8mg intravenous, palonosetron 0.25 mg intravenous 30 min before chemotherapy on scheduled D1 followed by aprepitant 80 mg on Day2 and Day3.The primary end point was the proportion of patients with no emetic episodes and no rescue medication [complete response (CR)] during the 24 h after chemotherapy administration (acute period).
Results: Out of 83 patients observed males were 49 and females were 34 and with performance status 0, total of 47.56 (68%) achieved complete response in overall period. This includes 62 patients (74%) in acute period and 49 patients (59%) in delayed period.
Conclusion: Aprepitant along with palonosetron and dexamethasone effectively and significantly prevents chemotherapy induced nausea and vomiting.

Keywords: Aprepitant, nausea and vomiting, palonosetron

How to cite : Devi S, Geeta M, Role of aprepitant in chemotherapy induced nausea and vomiting. IP Indian J Anat Surg Head Neck Brain 2016;2(2):35-39

Copyright © 2016 by author(s) and IP Indian J Anat Surg Head Neck Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)